Filing Details
- Accession Number:
- 0001209191-18-039668
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-27 16:47:58
- Reporting Period:
- 2018-06-25
- Accepted Time:
- 2018-06-27 16:47:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645666 | Kezar Life Sciences Inc. | KZR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1273885 | M Franklin Berger | C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-25 | 262,907 | $0.00 | 316,081 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2018-06-25 | 197,076 | $0.00 | 513,157 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2018-06-25 | 50,000 | $15.00 | 563,157 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-06-25 | 262,907 | $0.00 | 262,907 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2018-06-25 | 197,076 | $0.00 | 197,076 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
Billionaire Hedge Funds
